| The structure of glycosaminoglycans and their interactions with proteins NS Gandhi, RL Mancera Chemical biology & drug design 72 (6), 455-482, 2008 | 1336 | 2008 |
| New anti-tuberculosis drugs in clinical trials with novel mechanisms of action EC Rivers, RL Mancera Drug Discovery Today 13 (23-24), 1090-1098, 2008 | 222 | 2008 |
| Ligand− protein docking with water molecules BC Roberts, RL Mancera Journal of chemical information and modeling 48 (2), 397-408, 2008 | 201 | 2008 |
| WaterScore: a novel method for distinguishing between bound and displaceable water molecules in the crystal structure of the binding site of protein-ligand complexes AT García-Sosa, RL Mancera, PM Dean Journal of molecular modeling 9 (3), 172-182, 2003 | 170 | 2003 |
| Heparin/heparan sulphate-based drugs NS Gandhi, RL Mancera Drug discovery today 15 (23-24), 1058-1069, 2010 | 138 | 2010 |
| A molecular mechanism of solvent cryoprotection in aqueous DMSO solutions JB Mandumpal, CA Kreck, RL Mancera Physical Chemistry Chemical Physics 13 (9), 3839-3842, 2011 | 136 | 2011 |
| Current issues in plant cryopreservation A Kaczmarczyk, B Funnekotter, A Menon, PY Phang, A Al-Hanbali, ... Current frontiers in cryobiology 14, 417-438, 2012 | 133 | 2012 |
| Prediction of heparin binding sites in bone morphogenetic proteins (BMPs) NS Gandhi, RL Mancera Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1824 (12), 1374-1381, 2012 | 124 | 2012 |
| Ligand− protein cross-docking with water molecules R Thilagavathi, RL Mancera Journal of chemical information and modeling 50 (3), 415-421, 2010 | 113 | 2010 |
| Molecular dynamics simulations of the interactions of DMSO with DPPC and DOPC phospholipid membranes ZE Hughes, AE Mark, RL Mancera The journal of physical chemistry B 116 (39), 11911-11923, 2012 | 102 | 2012 |
| Inhibitors of xanthine oxidase: scaffold diversity and structure‐based drug design G Luna, AV Dolzhenko, RL Mancera ChemMedChem 14 (7), 714-743, 2019 | 99 | 2019 |
| Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system B Garcia-Bloj, C Moses, A Sgro, J Plani-Lam, M Arooj, C Duffy, ... Oncotarget 7 (37), 60535, 2016 | 95 | 2016 |
| Expanded interaction fingerprint method for analyzing ligand binding modes in docking and structure-based drug design MD Kelly, RL Mancera Journal of chemical information and computer sciences 44 (6), 1942-1951, 2004 | 89 | 2004 |
| Molecular modeling of hydration in drug design. RL Mancera Current Opinion in Drug Discovery & Development 10 (3), 275-280, 2007 | 88 | 2007 |
| Molecular dynamics simulation of dilute aqueous DMSO solutions. A temperature-dependence study of the hydrophobic and hydrophilic behaviour around DMSO RL Mancera, M Chalaris, K Refson, J Samios Physical Chemistry Chemical Physics 6 (1), 94-102, 2004 | 87 | 2004 |
| New anti-tuberculosis drugs with novel mechanisms of action EC Rivers, RL Mancera Current medicinal chemistry 15 (19), 1956-1967, 2008 | 80 | 2008 |
| Computer simulation of the structural effect of pressure on the hydrophobic hydration of methane PL Chau, RL Mancera Molecular Physics 96 (1), 109-122, 1999 | 79 | 1999 |
| Cryopreservation of threatened native Australian species—what have we learned and where to from here? A Kaczmarczyk, SR Turner, E Bunn, RL Mancera, KW Dixon In Vitro Cellular & Developmental Biology-Plant 47 (1), 17-25, 2011 | 77 | 2011 |
| The concentration effect on the ‘hydrophobic’and ‘hydrophilic’behaviour around DMSO in dilute aqueous DMSO solutions. A computer simulation study RL Mancera, M Chalaris, J Samios Journal of molecular liquids 110 (1-3), 147-153, 2004 | 77 | 2004 |
| Molecular dynamics simulation of small molecules interacting with biological membranes C Martinotti, L Ruiz‐Perez, E Deplazes, RL Mancera ChemPhysChem 21 (14), 1486-1514, 2020 | 76 | 2020 |
